All news

Investors show faith in Biopure

Investors show faith in Biopure

By Gregory Roumeliotis

Oxygen therapeutics company Biopure has announced another $3
million (€2.5 million) public offering to boost its working
capital, despite its major drug for humans, Hemopure, an artificial
blood product, being licensed only in South...

Follow us

Products

View more

Webinars